This could be an important finding, as FOXA1 is a well-known AR collaborator and driver of PCa, and AR cistrome reprogramming; any role of FOXA1 in the noncanonical AR cistrome in response to AR-targeted therapies has yet to be identified. This evidence concerns the gene AR and posterior cortical atrophy.